-
Chuck Schumer Says Democrats Won't Help Trump Send $300 Billion To Iran: US 'Worse Off' Due To President's 'Incompetence'
2026 Jun 18, 10:32pm | 781Read More...Senate Democratic leader Chuck Schumer (D-N.Y.) said on Thursday that Democrats would not support any funding effort tied to President Donald Trump's Iran agreement, accusing Trump of acting out of "incompetence" and "ego" as backlash grew over a proposed $300 billion reconstruction plan for Tehran...
-
Relmada's Cancer Drug Candidate Sparks Fresh Bullish Call
2026 Jun 18, 1:38pm | 610Read More...On Thursday, HC Wainwright initiated coverage on Relmada Therapeutics Inc. (NASDAQ:RLMD) with a primary focus on bladder cancer treatment regimen. The clinical-stage biotechnology company is focused on developing therapies for oncology and central nervous system conditions, with NDV-01 and...
-
Immix Biopharma Analyst Bullish But Flags Safety, Adoption Questions
2026 Jun 18, 1:38pm | 635Read More...Bank of America (BofA) Securities initiated coverage on Immix Biopharma Inc. (NASDAQ:IMMX), driven by NXC-201 in AL amyloidosis. AL amyloidosis is a rare plasma cell disorder wherein abnormal plasma cells in the bone marrow overproduce misfolded antibody proteins (light chains). These proteins...
-
Butterfly Network Climbs On Midjourney Hype Despite FDA, Reimbursement Questions
2026 Jun 18, 12:59pm | 808Read More...Butterfly Network Inc. (NYSE:BFLY) stock is trading higher on Thursday after it commented on Midjourney's announcement of Midjourney Medical and the Midjourney Scanner, a full-body tomographic imaging system. Elon Musk replied to the announcement on X, calling it "cool” and several unrelated...
-
FDA Expands Merck Pneumococcal Shot Label To Include At-Risk Children And Teens
2026 Jun 18, 11:29am | 499Read More...The U.S. FDA on Thursday approved an expanded indication for Merck & Co Inc.’s (NYSE:MRK) Capvaxive, extending its use to children and adolescents ages 2–17 with chronic conditions who have completed a primary pneumococcal vaccine series. The decision makes Capvaxive the only pneumococcal...
-
Biogen To Acquire RayThera For Up To $1 Billion, Expanding Immunology Pipeline
2026 Jun 18, 11:07am | 565Read More...Biogen Inc. (NASDAQ:BIIB) on Wednesday agreed to acquire private biotechnology company RayThera Inc. for up to $1 billion. The company looks to further expand its immunology pipeline and broaden its reach into additional disease areas. The deal includes an upfront payment to RayThera shareholders,...
-
Hyperliquid, Aster, And The Hard Truth About Decentralized Exchanges In The US
2026 Jun 18, 11:03am | 1239Read More...While most are looking at the recent public feud between Changpeng Zhao and Star Xu as some like of popcorn moment, I looked at it as a misunderstanding about decentralized finance regulations. Changpeng Zhao recently praised the decentralized exchange Hyperliquid for its technological brilliance....
-
Congressional Trading Report: Rep. Matt Van Epps Sold Over $27K In Tapestry Stock
2026 Jun 18, 11:00am | 581Read More...A report on June 17, 2026 shows that Representative Matt Van Epps from Tennessee sale stock in Tapestry (NYSE:TPR), valued between $27,013 and $230,000. According to the June filing, the transaction occurred on June 16, 2026. At the time of writing, Tapestry shares are trading down 0.28% at $145.46...
-
Novocure Brain Cancer Study Shows No Significant Survival Benefit, Stock Tanks
2026 Jun 18, 10:09am | 622Read More...Novocure Ltd. (NASDAQ:NVCR) on Thursday reported topline results from its Phase 3 TRIDENT study. The data showed that starting Tumor Treating Fields (TTFields) therapy during chemoradiation did not significantly improve overall survival compared with initiating the therapy during the maintenance...
-
Goldman Sachs Warns Big Tech's $770 Billion AI Spending Frenzy Could Backfire— Here's Why
2026 Jun 18, 9:00am | 1068Read More...Wall Street bank Goldman Sachs has issued a warning for tech titans like Amazon.com Inc. (NASDAQ:AMZN) and Microsoft Corp.(NASDAQ:MSFT), noting that their Return on Equity (ROE) faces severe downward pressure as massive artificial intelligence capital expenditures trigger escalating “...
-
Why Is Legend Biotech Stock Falling Thursday?
2026 Jun 18, 8:27am | 701Read More...Legend Biotech Corp. (NASDAQ:LEGN) stock fell in Thursday’s premarket trading after the cell therapy company priced an underwritten public offering of 7.7 million American Depositary Shares (ADSs) at $29.35 per ADS. The offering is expected to raise about $226 million before underwriting...
-
Forget The June Fed Pause: Citadel Warns 'Second-Round Effects' Will Force A September Rate Hike
2026 Jun 18, 7:33am | 829Read More...Investors assessing the Federal Reserve's decision to keep interest rates steady this week may be suffering from a false sense of security. According to a global macro strategy report authored by Frank Flight at Citadel Securities, the market is severely under-indexing a looming hawkish pivot. The...
-
Trump Settles $100 Million Lawsuit With Niece Who Called Him 'The World's Most Dangerous Man'
2026 Jun 18, 6:58am | 673Read More...President Donald Trump has settled a $100 million lawsuit against his niece, Mary Trump. The lawsuit was filed over accusations that Mary Trump leaked financial information and family tax documents to The New York Times. The settlement was announced in a letter filed on Tuesday...
-
Joe Rogan Says Former Presidents Contacted Spotify Behind The Scenes To Push For His Show's Removal: 'They Spent A Lot Of Money'
2026 Jun 18, 4:25am | 550Read More...Podcast host Joe Rogan alleged that former U.S. presidents were among those who contacted Spotify Technology SA (NYSE:SPOT) during the height of the backlash against his podcast over COVID-19 discussions, alleging a coordinated effort to have his show removed from the audio streaming platform....
-
Thomas Massie Says 'I'm Tired Of Winning' As Haley, Pence And Murphy Blast Trump's 14-Point Iran Memorandum
2026 Jun 18, 4:06am | 877Read More...Trump allies and critics blasted the U.S.-Iran memorandum on social media Wednesday after Washington released the official text of a 14-point framework that outlines plans to reopen the Strait of Hormuz, ease financial restrictions on Tehran and pursue further talks on Iran's nuclear program....
















